Rp-cAMPS triethylammonium salt is a membrane-permeable, competitive cAMP antagonist that inhibits cAMP-induced activation of PKA I and PKA II (Ki = 6.05 µM and 9.75 µM, respectively) by binding to the regulatory subunits without dissociating the kinase holoenzyme; it blocks synaptic plasticity without affecting normal synaptic transmission; it significantly reduces monosynaptic EPSCs at PB-CeLC and BLA-CeLC synapses in slices from arthritic rats, but not in control neurons from normal animals.